Impaired right and left ventricular function and relaxation induced by pulmonary regurgitation are not reversed by tardive anti-fibrosis treatment
Pulmonary regurgitation (PR) after repair of tetralogy of Fallot (TOF) is associated with progressive right (RV) and left (LV) ventricular dysfunction and fibrosis. However, angiotensin Ⅱ receptor blockade therapy has shown mixed and often disappointing results. The aim of this study was to serially assess changes in biventricular remodeling, dysfunction and interactions in a rat model of isolated severe PR and to study the effects of angiotensin Ⅱ receptor blockade. PR was induced in Sprague-Dawley rats by leaflet laceration. Shams (n=6) were compared to PR (n=5) and PR+losartan treatment (n=6). In the treatment group, oral losartan (50mg/kg/day) was started 6-weeks after PR induction and continued for 6-weeks until the terminal experiment. In all groups serial echocardiography was performed every 2 weeks until the terminal experiment where biventricular myocardium was harvested and analyzed for fibrosis. PR and PR+losartan rats experienced early progressive RV dilatation by 2-weeks which then stabilized. RV systolic dysfunction occurred from 4-weeks after insult and gradually progressed. In PR rats, RV dilatation caused diastolic LV compression and impaired relaxation. PR rats developed increased RV fibrosis compared to shams. While losartan decreased RV fibrosis RV dilatation and dysfunction were not improved. This suggests that RV dilatation is an early consequence of PR and affects LV relaxation. RV dysfunction may progress independent of further remodeling, suggesting that late pulmonary valve implantation may not improve RV function. Reduced RV fibrosis was not associated with improved RV function and may not be a viable therapeutic target in rTOF with predominant RV volume-loading.